Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.

Hannah (Giger Lab) has been awarded an NIH F31.

The W.M. Keck Foundation has awarded $1.3M to Assistant Professor Ryan Baldridge, Biological Chemistry, and Corydon Ford Collegiate Professor Billy Tsai, CDB, to develop a next-generation protein degradation technology to revolutionize antiviral treatments for endoplasmic reticulum (ER) dysfunction.

"Intrahepatic paracrine signaling by cardiotrophin‐like cytokine factor 1 ameliorates diet‐induced NASH in mice," has been published in Hepatology.

Jiaqian Li (Hanson Lab) has been awarded a Rackham International Student Fellowship!

Read Cell & Developmental Biology's 2023 annual report.

Pilar Rivero-Rios and Lois Weisman just published a Perspective in Science

New Publication by Seth Teague and LiAng Yao (Heemskerk Lab)

New Publication by Emily Freeburne and Colleagues (Heemskerk Lab)

Pearce, professor of epidemiology at the School of Public Health and co-lead of Rogel’s cancer control and population sciences program, reflects on the project and why bringing this study to Michigan is so critical.

The holidays are a great time to discuss your family's medical history. Learn the importance of discussing your family's health history & how to bring it up.

Researchers from the University of Michigan Health Rogel Cancer Center have developed a monitoring system using a research genetics program to trigger alerts about cancer patients suspected to have the DPYD gene variant.

New publication by Jeffrey Knupp and Madison Pletan (Tsai Lab)

Congratulations to Ryan Passino! Ryan (Giger Lab) successfully defended his thesis.

Congratulations to Emily Freeburne! Emily (Heemskerk Lab) successfully defended her thesis.